HealthWorld's Most Expensive Gene Therapy Zolgensma Treats Rare Genetic Disease In Infants The Food and Drug Administration has approved the use of Zolgensma in treating a rare genetic disease in infants. At a one-time treatment, Zolgensma costs at least $2.1 million.by Alyssa Navarro
HealthAmbien, Other Insomnia Drugs Get FDA’s Strongest Warning For Their Troubling Side Effectsby Naia Carlos
HealthFDA Expands Lists Of Blood Pressure Drugs Recalled For Potentially Carcinogenic Ingredientby Diane Samson
HealthFDA Warns Of Pre-owned, Unauthorized Medical Test Strips Sold Through Amazon, eBay, And Craigslistby Ted Ranosa
HealthFDA Added Sugar Label On Packed Food And Drinks May Prevent 1 Million Cases Of Cardiometabolic Diseasesby Maui Hermitanio
HealthFDA Keeps Secret Database Of Medical Device-Related Injuries And Malfunctions, Report Claimsby Naia Carlos
HealthNational Cancer Institute Director Ned Sharpless To Be Acting FDA Commissionerby Maureen Hermitanio